fluoxetine has been researched along with Bewilderment in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 48-year-old man presented to the emergency department with confusion, agitation, diaphoresis, and muscle rigidity after beginning treatment with fluoxetine, a serotonin reuptake inhibitor." | 7.69 | Fluoxetine and the serotonin syndrome. ( Ruiz, F, 1994) |
| "A 48-year-old man presented to the emergency department with confusion, agitation, diaphoresis, and muscle rigidity after beginning treatment with fluoxetine, a serotonin reuptake inhibitor." | 3.69 | Fluoxetine and the serotonin syndrome. ( Ruiz, F, 1994) |
| "To quantify the importance of drug-drug interactions (DDIs) in the occurrence of adverse drug reactions (ADRs) reported with serotoninergic reuptake inhibitors in a pharmacovigilance database." | 1.38 | The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France. ( Bagheri, H; Bondon-Guitton, E; Bui, E; Durrieu, G; Lapeyre-Mestre, M; Montastruc, F; Montastruc, JL; Schmitt, L; Sommet, A, 2012) |
| "Serotonin syndrome is the result of the drug interaction that enhances serotonergic tone in the central nervous system." | 1.30 | Serotonin syndrome presenting with migrainelike stroke. ( Molaie, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montastruc, F | 1 |
| Sommet, A | 1 |
| Bondon-Guitton, E | 1 |
| Durrieu, G | 1 |
| Bui, E | 1 |
| Bagheri, H | 1 |
| Lapeyre-Mestre, M | 1 |
| Schmitt, L | 1 |
| Montastruc, JL | 1 |
| Ruiz, F | 1 |
| Molaie, M | 1 |
| Feighner, JP | 1 |
| Boyer, WF | 1 |
| Tyler, DL | 1 |
| Neborsky, RJ | 1 |
4 other studies available for fluoxetine and Bewilderment
| Article | Year |
|---|---|
The importance of drug-drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Antidepressive Agents; Citalopram; Conf | 2012 |
Fluoxetine and the serotonin syndrome.
Topics: Akathisia, Drug-Induced; Confusion; Drug Therapy, Combination; Emergency Medicine; Fluoxetine; Human | 1994 |
Serotonin syndrome presenting with migrainelike stroke.
Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Clomipramine; Confusi | 1997 |
Adverse consequences of fluoxetine-MAOI combination therapy.
Topics: Adult; Akathisia, Drug-Induced; Confusion; Depressive Disorder; Drug Interactions; Drug Therapy, Com | 1990 |